Gal Akiri

1.7k total citations
15 papers, 1.4k citations indexed

About

Gal Akiri is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Gal Akiri has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Oncology. Recurrent topics in Gal Akiri's work include Wnt/β-catenin signaling in development and cancer (7 papers), Cancer-related gene regulation (7 papers) and Kruppel-like factors research (4 papers). Gal Akiri is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (7 papers), Cancer-related gene regulation (7 papers) and Kruppel-like factors research (4 papers). Gal Akiri collaborates with scholars based in United States, Israel and Argentina. Gal Akiri's co-authors include Stuart A. Aaronson, Ofra Kessler, Gera Neufeld, Luca Grumolato, Ajish George, Ravi Sachidanandam, Guizhong Liu, Dorit Nahari, Orna Elroy‐Stein and Shu‐Yun Le and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Gal Akiri

15 papers receiving 1.3k citations

Peers

Countries citing papers authored by Gal Akiri

Since Specialization

Citations

This map shows the geographic impact of Gal Akiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gal Akiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gal Akiri more than expected).

Fields of papers citing papers by Gal Akiri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gal Akiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gal Akiri. The network helps show where Gal Akiri may publish in the future.

Co-authorship network of co-authors of Gal Akiri

This figure shows the co-authorship network connecting the top 25 collaborators of Gal Akiri. A scholar is included among the top collaborators of Gal Akiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gal Akiri. Gal Akiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Localized LoxL3-Dependent Fibronectin Oxidation Regulates Myofiber Stretch and Integrin-Mediated Adhesion 2016 ·Developmental Cell ·(unknown), Shelly Zaffryar‐Eilot, Olga Genin, (unknown), Sharon Soueid‐Baumgarten, Ofra Kessler, (unknown), Gal Akiri, Gera Neufeld, Yuval Cinnamon, Peleg Hasson	42
2	A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis 2013 ·Cell Death and Differentiation ·(unknown), Gal Akiri, Ajish George, Ravi Sachidanandam, Stuart A. Aaronson	195
3	β-Catenin-Independent Activation of TCF1/LEF1 in Human Hematopoietic Tumor Cells through Interaction with ATF2 Transcription Factors 2013 ·PLoS Genetics ·Luca Grumolato, Guizhong Liu, Tomomi Haremaki, Sathish Kumar Mungamuri, Phyllus Y. Mong, Gal Akiri, Pablo Lopez‐Bergami, Adriana Arita, Youssef Anouar, Marek Mlodzik, Ze’ev A. Ronai, Joshua Brody, Daniel C. Weinstein, Stuart A. Aaronson	54
4	Tu1898 Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 2013 ·Gastroenterology ·Stefania Asciutti, Emidio Camaioni, Phyllus Y. Mong, Noa Biran, Andrea Carotti, Paride Liscio, Gal Akiri, Roberto Pellicciari, Stuart A. Aaronson	1
5	Wnt Pathway Activation Predicts Increased Risk of Tumor Recurrence in Patients With Stage I Nonsmall Cell Lung Cancer 2012 ·Annals of Surgery ·Mark Shapiro, Gal Akiri, Cynthia Chin, Juan P. Wisnivesky, Mary Beth Beasley, Todd S. Weiser, Steven Swanson, Stuart A. Aaronson	41
6	High-Frequency Canonical Wnt Activation in Multiple Sarcoma Subtypes Drives Proliferation through a TCF/β-Catenin Target Gene, CDC25A 2011 ·Cancer Cell ·Sapna Vijayakumar, Guizhong Liu, (unknown), Shen Yao, Yan Chen, Gal Akiri, Luca Grumolato, Stuart A. Aaronson	108
7	Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells 2010 ·Oncogene ·Stefania Asciutti, Gal Akiri, Luca Grumolato, Srinivasan Vijayakumar, Stuart A. Aaronson	14
8	Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma 2009 ·Oncogene ·Gal Akiri, Mathew Cherian, Srinivasan Vijayakumar, (unknown), Anna Bafico, Stuart A. Aaronson	119
9	Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells 2009 ·The Journal of Cell Biology ·Guizhong Liu, Sapna Vijayakumar, Luca Grumolato, Randy Arroyave, (unknown), Gal Akiri, Stuart A. Aaronson	134
10	Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells 2009 ·The Journal of Experimental Medicine ·Guizhong Liu, Sapna Vijayakumar, Luca Grumolato, Randy Arroyave, (unknown), Gal Akiri, Stuart A. Aaronson	4
11	Semaphorin-3B Is an Angiogenesis Inhibitor That Is Inactivated by Furin-Like Pro-Protein Convertases 2008 ·Cancer Research ·Asya Varshavsky, Ofra Kessler, (unknown), Boaz Kigel, (unknown), Gal Akiri, Gera Neufeld	104
12	Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2 2005 ·Journal of Hepatology ·Zehava Vadasz, Ofra Kessler, Gal Akiri, Stela Gengrinovitch, Herbert M. Kagan, Yaacov Baruch, Ofer Ben Izhak, Gera Neufeld	150
13	VEGF receptor expression on reactive breast cancer stroma: paving the way for tumor invasion 2005 ·Journal of Clinical Oncology ·(unknown), Gal Akiri, Dong Jin, Sergey V. Shmelkov, (unknown), (unknown), Yiping Wu, Dan Hicklin, (unknown), Linda T. Vahdat	4
14	Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo. 2003 ·PubMed ·Gal Akiri, Edmond Sabo, Hagit Dafni, Zehava Vadasz, (unknown), (unknown), Ofra Kessler, Tzafra Cohen, Murray B. Resnick, Michal Neeman, Gera Neufeld	168
15	Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription 1998 ·Oncogene ·Gal Akiri, Dorit Nahari, (unknown), Shu‐Yun Le, Orna Elroy‐Stein, (unknown)	216

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact